Microbot Medical Inc.
MBOT
$1.46
-$0.04-2.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 129.52% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 129.52% | -- | |||
| Cost of Revenue | 758.25% | -- | |||
| Gross Profit | -32,250.00% | -- | |||
| SG&A Expenses | 21.62% | -44.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.29% | 6.94% | |||
| Operating Income | -43.24% | -4.40% | |||
| Income Before Tax | -53.28% | -5.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -53.28% | -5.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -53.28% | -5.98% | |||
| EBIT | -43.24% | -4.40% | |||
| EBITDA | -43.29% | -4.36% | |||
| EPS Basic | -53.20% | -6.21% | |||
| Normalized Basic EPS | -53.22% | -6.21% | |||
| EPS Diluted | -53.20% | -6.21% | |||
| Normalized Diluted EPS | -53.22% | -6.21% | |||
| Average Basic Shares Outstanding | 0.01% | -0.22% | |||
| Average Diluted Shares Outstanding | 0.01% | -0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||